Targeted therapy in advanced colon cancer: the role of new therapies

Ann Oncol. 2004:15 Suppl 4:iv55-62. doi: 10.1093/annonc/mdh905.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Clinical Trials as Topic
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology*
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use*
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / drug effects
  • ErbB Receptors / physiology*
  • Humans
  • Neovascularization, Pathologic
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*
  • Receptors, Vascular Endothelial Growth Factor / drug effects
  • Receptors, Vascular Endothelial Growth Factor / physiology*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Cyclooxygenase Inhibitors
  • ErbB Receptors
  • Receptors, Vascular Endothelial Growth Factor